Table 3.
Recording condition | Control decay time (ms) | NE/agonist decay time (ms) | t | df | p | % of control | t | df | p |
---|---|---|---|---|---|---|---|---|---|
sIPSCs NE (KCl int.) | 7.13 ± 0.48 | 7.46 ± 0.54 | 2.11 | 12 | 0.06 | 104.47 ± 2.27 | 1.97 | 12 | 0.07 |
sIPSCs NE | 8.91 ± 0.50 | 9.18 ± 0.52 | 0.73 | 12 | 0.48 | 103.93 ± 3.92 | 1 | 12 | 0.34 |
mIPSCs NE | 7.08 ± 0.25 | 7.80 ± 0.29 | 6.03 | 18 | <0.0001∗ | 110.44 ± 1.57 | 6.67 | 18 | <0.0001∗ |
sIPSCs PHE | 8.62 ± 0.50 | 9.16 ± 0.49 | 1.79 | 9 | 0.11 | 107.04 ± 3.50 | 2.01 | 9 | 0.08 |
mIPSCs PHE | 8.08 ± 1.07 | 8.64 ± 0.97 | 1.9 | 5 | 0.16 | 108.55 ± 4.40 | 1.95 | 5 | 0.11 |
sIPSCs UK14304 | 8.28 ± 0.43 | 8.06 ± 0.28 | 0.96 | 6 | 0.37 | 98.03 ± 2.81 | 0.7 | 6 | 0.51 |
mIPSCs UK14304 | 6.76 ± 0.46 | 7.32 ± 0.46 | 4.92 | 5 | 0.004∗ | 108.52 ± 1.63 | 4.53 | 5 | 0.006∗ |
sIPSCs Isoprenaline | 7.46 ± 0.65 | 7.92 ± 0.66 | 1.33 | 4 | 0.25 | 106.57 ± 3.72 | 1.4 | 4 | 0.24 |
mIPSCs Isoprenaline | 7.79 ± 0.35 | 8.12 ± 0.27 | 2.01 | 6 | 0.09 | 104.68 ± 2.35 | 1.99 | 6 | 0.07 |
∗p < 0.05.